Theo Heller
National Institutes of Health · 498 works · 23,225 citations · h-index 67
Top works
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
- Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
- Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
- JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
- Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
- Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C
- Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
- The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
- Nodular regenerative hyperplasia: Not all nodules are created equal
- Common Severe Infections in Chronic Granulomatous Disease
- Danazol Treatment for Telomere Diseases
- Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- An in vitro model of hepatitis C virion production
- Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
- Pathogenesis of hepatitis C—associated hepatocellular carcinoma
- Effects of antiviral therapy on the cellular immune response in acute hepatitis C